THOUSAND OAKS
Live / Registered — Registered (as of 14 Mar 2023)
What this means for you
Registered since 14 Mar 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90272699
- Registration number
- 7001106
- Mark type
- Design + words
- Filed
- 22 Oct 2020
- Published for opposition
- 26 Oct 2021
- Registered
- 14 Mar 2023
- Attorney of record
- Max Vern
Goods and services
- Class 042 — Scientific and technological services: Technological research in the field of biopharma; research and development of new products for others; biological research; development of pharmaceutical preparations and pharmaceuticals; pharmaceutical drug development services; pharmaceutical research services; pharmaceutical product evaluation, namely, drug evaluation; medical research
Owner
- Thousand Oaks Biopharma (Nantong) Co., Ltd., Haimen Nantong Jiangsu, CN
- Thousand Oaks Biopharma (Nantong) Co., Ltd., Haimen Nantong Jiangsu, CN
- Thousand Oaks Biopharma (Nantong) Co., Ltd., Haimen Nantong Jiangsu, CN
Prosecution history
- 14 Mar 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 Mar 2023 — REGISTERED-PRINCIPAL REGISTER
- 09 Feb 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Feb 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jan 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 15 Dec 2022 — USE AMENDMENT FILED
- 18 Jan 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 Dec 2022 — TEAS STATEMENT OF USE RECEIVED
- 23 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2022 — SOU EXTENSION 1 GRANTED
- 21 Jun 2022 — SOU EXTENSION 1 FILED
- 21 Jun 2022 — SOU TEAS EXTENSION RECEIVED
- 21 Dec 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Oct 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Oct 2021 — PUBLISHED FOR OPPOSITION